PMC:7441788 / 22435-22893
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T105 | 432-440 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T196 | 165-166 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T197 | 199-200 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T198 | 281-282 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T199 | 317-318 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T200 | 344-345 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T256 | 84-89 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T257 | 119-121 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T258 | 131-133 | Chemical | denotes | SD | http://purl.obolibrary.org/obo/CHEBI_74807 |
| T259 | 157-159 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T260 | 167-176 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T261 | 201-210 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T262 | 273-275 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T263 | 283-292 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T264 | 319-328 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T265 | 364-366 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T266 | 393-402 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T145 | 119-121 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T146 | 157-159 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T147 | 167-176 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T148 | 201-210 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T149 | 273-275 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T150 | 283-292 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T151 | 319-328 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T152 | 364-366 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T153 | 393-402 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T107 | 432-440 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T167 | 0-458 | Sentence | denotes | Mehraet al[61] Multinational real-world analysis Teatment groups: n = 14,888Control group: n = 81,144 Mean daily dose: CQ 765 mg, (SD 308); HCQ 596 mg(126); CQ with a macrolide 790 mg(320); HCQ with a macrolide 597 mg(128).mean duration:CQ 6.6 days(2.4); HCQ 4.2 days(1.9);CQ with a macrolide 6.8 days(2.5); HCQ with a macrolide 4.3 days (2.0) A benefit of HCQ or CQ, when used alone or witha macrolide, on in-hospital outcomes for COVID-19 was not observed. |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T98 | 432-440 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T167 | 0-458 | Sentence | denotes | Mehraet al[61] Multinational real-world analysis Teatment groups: n = 14,888Control group: n = 81,144 Mean daily dose: CQ 765 mg, (SD 308); HCQ 596 mg(126); CQ with a macrolide 790 mg(320); HCQ with a macrolide 597 mg(128).mean duration:CQ 6.6 days(2.4); HCQ 4.2 days(1.9);CQ with a macrolide 6.8 days(2.5); HCQ with a macrolide 4.3 days (2.0) A benefit of HCQ or CQ, when used alone or witha macrolide, on in-hospital outcomes for COVID-19 was not observed. |